Clinical Trial Update: A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis [Phase 2]

View source ↗

Summary

Phase 2 study of VVN461 ophthalmic solution for noninfectious anterior uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noninfectious Anterior Uveitis

Drugs mentioned

• VVN461 ophthalmic solution (VVN461)

Snippet

Sponsor: VivaVision Biotech, Inc | Conditions: Anterior Uveitis | Phase 2 | Status: COMPLETED